Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Lymphoblastic Lymphoma (LBL)”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 14 of 0 results

Testing effectiveness (Phase 2)Study completedNCT00003545
What this trial is testing

506U78 in Treating Patients With Refractory or Relapsed Acute Lymphoblastic Leukemia or Lymphoblastic Lymphoma

Who this might be right for
LeukemiaLymphoma
National Cancer Institute (NCI) 35
Not applicableNot Yet RecruitingNCT06741813
What this trial is testing

Allo-HSCT vs ASCT in Adult T-LBL

Who this might be right for
T Lymphoblastic Lymphoma
Peking University People's Hospital 230
Very early researchStudy completedNCT05907603
What this trial is testing

Research Development（RD）13-02 Chimeric Antigen Receptor(CAR) -T Cell Injection for Patients With r/r Cluster Of Differentiation 7（CD7）+ T-Acute Lymphoblastic Leukemia(ALL)/T-Lymphoblastic Lymphoma(LBL) /Acute Myelogenous Leukemia(AML)

Who this might be right for
NeoplasmsHematologic NeoplasmsHematologic Diseases
Kai Lin Xu，MD 8
Not applicableStudy completedNCT00866671
What this trial is testing

Observational Study of Nelarabine in Children and Young Adults

Who this might be right for
Leukaemia, Lymphoblastic, Acute
GlaxoSmithKline 28
Early research (Phase 1)Looking for participantsNCT07106749
What this trial is testing

CD180 CART for Relapsed or Refractory CD180 Positive Hematologic Malignancies

Who this might be right for
Acute Myeloid LeukemiaB Acute Lymphoblastic Leukemia/Lymphoma
Institute of Hematology & Blood Diseases Hospital, China 12
Testing effectiveness (Phase 2)Ended earlyNCT02257684
What this trial is testing

A Dose Confirmation and Pharmacokinetic Study of Pegcrisantaspase Administered as Intravenous (IV) Infusion in Children and Young Adults With Acute Lymphoblastic Leukemia (ALL) /Lymphoblastic Lymphoma (LBL). Following Hypersensitivity to Pegaspargase (Oncaspar)

Who this might be right for
Acute Lymphoblastic LeukemiaLymphoblastic Lymphoma
Jazz Pharmaceuticals 4
Not applicableUnknownNCT01619124
What this trial is testing

Osteonecroses in Pediatric Patients With ALL

Who this might be right for
OsteonecrosisAcute Lymphoblastic LeukaemiaLymphoblastic Lymphoma
Klinik für Kinder-Onkologie, -Hämatologie und Klinische Immu 400
Testing effectiveness (Phase 2)Looking for participantsNCT06207123
What this trial is testing

Investigate LP-118, Ponatinib, Vincristine and Dexamethasone in Relapsed/Refractory Acute Lymphoblastic Leukemia (ALL) or Lymphoblastic Lymphoma (LBL)

Who this might be right for
Acute LeukemiaLymphoblastic LeukemiaLymphoblastic Lymphoma
University of Chicago 15
Testing effectiveness (Phase 2)Active Not RecruitingNCT04315324
What this trial is testing

Study to Test OBI-3424 in Patients With T-Cell Acute Lymphoblastic Leukemia (T-ALL) or T-Cell Lymphoblastic Lymphoma (T-LBL)

Who this might be right for
Recurrent T Acute Lymphoblastic LeukemiaRefractory T Acute Lymphoblastic LeukemiaRefractory T Lymphoblastic Lymphoma+1 more
SWOG Cancer Research Network 67
Testing effectiveness (Phase 2)WithdrawnNCT06210750
What this trial is testing

Adding Targeted Drugs to Usual Chemotherapy for Adults With Newly Diagnosed T-Cell Acute Lymphoblastic Leukemia (T-ALL) and T-Cell Lymphoblastic Lymphoma (T-LBL)

Who this might be right for
T Acute Lymphoblastic LeukemiaT Lymphoblastic Lymphoma
National Cancer Institute (NCI)
Large-scale testing (Phase 3)UnknownNCT04446130
What this trial is testing

Study of Decitabine Combined With HAAG Regimen in Newly Diagnosed ETP-ALL/LBL, T/M-MPAL and ALL/LBL With Myeloid or Stem Cell Markers Patients

Who this might be right for
Induction ChemotherapyAcute T-Lymphocytic LeukemiaT-cell Lymphoblastic Lymphoma Leukemia+1 more
The First Affiliated Hospital of Soochow University 100
Not applicableApproved For MarketingNCT04943952
What this trial is testing

JZP458 - Recombinant Erwinia Asparaginase for Treatment of ALL / LBL Patients With Hypersensitivity to E. Coli-derived Asparaginase

Who this might be right for
Acute Lymphoblastic LeukemiaLymphoblastic Lymphoma
Jazz Pharmaceuticals
Early research (Phase 1)UnknownNCT05398614
What this trial is testing

SENL101 Autologous T Cell Injection in Adults With Relapsed or Refractory CD7+ Hematolymphoid Malignancies

Who this might be right for
T-ALLLymphoma, T-Cell
Hebei Senlang Biotechnology Inc., Ltd. 18
Early research (Phase 1)Ended earlyNCT01910428
What this trial is testing

L-asparaginase Encapsulated in Red Blood Cells (Eryaspase) for Treatment of Adult Patients With ALL or LBL

Who this might be right for
Acute Lymphoblastic LeukemiaLymphoblastic Lymphoma
ERYtech Pharma 14